Autotaxin (NPP-2) in the brain: Cell type-specific expression and regulation during development and after neurotrauma

Cellular and Molecular Life Sciences

Volumn 64, Issue 2, 2007, Pages 230-243

  Savaskan, N E ^a   Rocha, L ^b   Kotter, M R ^c   Baer, A ^c   Lubec, G ^c   Van Meeteren, L A ^a   Kishi, Y ^d,e   Aoki, J ^d,e   Moolenaar, W H ^a   Nitsch, R ^b   Brauer A U ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF TOKYO   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Axonal growth and regeneration; Brain development; G protein coupled receptors; Hippocampus; LPA signaling; Myelination; Oligodendrocyte precursor cells; S1P

Indexed keywords

AUTOTAXIN; ENZYME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CHOROID PLEXUS; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FEMALE; IN VIVO STUDY; MALE; NERVOUS SYSTEM INJURY; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; STEM CELL; SUBVENTRICULAR ZONE; UPREGULATION; WHITE MATTER;

ANIMALS; BRAIN; BRAIN INJURIES; CERCOPITHECUS AETHIOPS; COS CELLS; DNA PRIMERS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYSOPHOSPHOLIPIDS; MALE; NEUROGLIA; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 33846509825     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-006-6412-0     Document Type: Article

References (77)

1. Mills, G. B. and Moolenaar, W. H. (2003) The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer 3, 582-591.
2. Tigyi, G. and Parrill, A. L. (2003) Molecular mechanisms of lysophosphatidic acid action. Prog. Lipid Res. 42, 498-526.
3. Moolenaar, W. H., van Meeteren, L. A. and Giepmans, B. N. (2004) The ins and outs of lysophosphatidic acid signaling. Bioessays 26, 870-881.
4. Kingsbury, M. A., Rehen, S. K., Contos, J. J., Higgins, C. M. and Chun, J. (2003) Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding. Nat. Neurosci. 6, 1292-1299.
5. Fukushima, N., Weiner, J. A. and Chun, J. (2000) Lysophosphatidic acid (LPA) is a novel extracellular regulator of cortical neuroblast morphology. Dev. Biol. 228, 6-18.
6. Anliker, B. and Chun, J. (2004) Lysophospholipid G protein-coupled receptors. J. Biol. Chem. 279, 20555-20558.
7. Ishii, I., Fukushima, N., Ye, X. and Chun, J. (2004) Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. 73, 321-354.
8. Tokumura, A., Harada, K., Fukuzawa, K. and Tsukatani, H. (1986) Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma. Biochim. Biophys. Acta 875, 31-38.
9. Fukushima, N. and Chun, J. (2001) The LPA receptors. Prostaglandins Other Lipid Mediat. 64, 21-32.
10. Xie, Y., Gibbs, T. C., Mukhin, Y. V. and Meier, K. E. (2002) Role for 18:1 lysophosphatidic acid as an autocrine mediator in prostate cancer cells. J. Biol. Chem. 277, 32516-32526.
11. Hama, K., Bandoh, K., Kakehi, Y., Aoki, J. and Arai, H. (2002) Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors. FEBS Lett. 523, 187-192.
12. Sugiura, T., Nakane, S., Kishimoto, S., Waku, K., Yoshioka, Y. and Tokumura, A. (2002) Lysophosphatidic acid, a growth factor-like lipid, in the saliva. J. Lipid Res. 43, 2049-2055.
13. Aoki, J. (2004) Mechanisms of lysophosphatidic acid production. Semin. Cell Dev. Biol. 15, 477-489.
14. Xu, Y., Gaudette, D. C., Boynton, J. D., Frankel, A., Fang, X. J., Sharma, A., Hurteau, J., Casey, G., Goodbody, A., Mellors, A. et al. (1995) Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin. Cancer Res. 1, 1223-1232.
15. Siess, W., Zangl, K. J., Essler, M., Bauer, M., Brandl, R., Corrinth, C., Bittman, R., Tigyi, G. and Aepfelbacher, M. (1999) Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 96, 6931-6936.
16. Kusaka, S., Kapousta-Bruneau, N., Green, D. G. and Puro, D. G. (1998) Serum-induced changes in the physiology of mammalian retinal glial cells: role of lysophosphatidic acid. J. Physiol. 506, 445-458.
17. Tokumura, A., Majima, E., Kariya, Y., Tominaga, K., Kogure, K., Yasuda, K. and Fukuzawa, K. (2002) Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 277, 39436-39442.
18. Umezu-Goto, M., Kishi, Y., Taira, A., Hama, K., Dohmae, N., Takio, K., Yamori, T., Mills, G. B., Inoue, K., Aoki, J. and Arai, H. (2002) Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 158, 227-233.
19. Stracke, M. L., Krutzsch, H. C., Unsworth, E. J., Arestad, A., Cioce, V., Schiffmann, E. and Liotta, L. A. (1992) Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J. Biol. Chem. 267, 2524-2529.
20. Nam, S. W., Clair, T., Campo, C. K., Lee, H. Y., Liotta, L. A. and Stracke, M. L. (2000) Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells. Oncogene 19, 241-247.
21. Jansen, S., Stefan, C., Creemers, J. W. M., Waelkens, E., Van Eynde, A., Stalmans, W. and Bollen, M. (2005) Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D. J. Cell Sci. 118, 3081-3089.
22. Baumforth, K. R., Flavell, J. R., Reynolds, G. M., Davies, G., Pettit, T. R., Wei, W., Morgan, S., Stankovic, T., Kishi, Y., Arai, H., Nowakova, M., Pratt, G., Aoki, J., Wakelam, M. J., Young, L. S. and Murray, P. G. (2005) Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells. Blood 106, 2138-2146.
23. Kishi, Y., Okudaira, S., Tanaka, M., Hama, K., Shida, D., Kitayama, J., Yamori, T., Aoki, J., Fujimaki, T. and Arai, H. (2006) Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J. Biol. Chem. 281, 17492-17500.
24. Goding, J. W., Terkeltaub, R., Maurice, M., Deterre, P., Sali, A. and Belli, S. I. (1998) Ecto-phosphodiesterase/pyrophosphatase of lymphocytes and non-lymphoid cells: structure and function of the PC-1 family. Immunol. Rev. 161, 11-26.
25. Bollen, M., Gijsbers, R., Ceulemans, H., Stalmans, W. and Stefan, C. (2000) Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit. Rev. Biochem. Mol. Biol. 35, 393-432.
26. Stefan, C., Jansen, S. and Bollen, M. (2005) NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem. Sci. 30, 542-550.
27. Ohe, Y., Ohnishi, H., Okazawa, H., Tomizawa, K., Kobayashi, H., Okawa, K. and Matozaki, T. (2003) Characterization of nucleotide pyrophosphatase-5 as an oligomannosidic glycoprotein in rat brain. Biochem. Biophys. Res. Commun. 308, 719-725.
28. Sakagami, H., Aoki, J., Natori, Y., Nishikawa, K., Kakehi, Y., Natori, Y. and Arai, H. (2005) Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family. J. Biol. Chem. 280, 23084-23093.
29. Duan, R. D., Bergman, T., Xu, N., Wu, J., Cheng, Y., Duan, J., Nelander, S., Palmberg, C. and Nilsson, A. (2003) Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family. J. Biol. Chem. 278, 38528-38536.
30. Goding, J. W., Grobben, B. and Slegers, H. (2003) Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/ phosphodiesterase family. Biochim. Biophys. Acta 1638, 1-19.
31. van Meeteren, L. A., Ruurs, P., Christodoulou, E., Goding, J. W., Takakusa, H., Kikuchi, K., Perrakis, A., Nagano, T. and Moolenaar, W. H. (2005) Inhibition of autotaxin by lysophosphatidic acid and sphingosine-1-phosphate. J. Biol. Chem. 280, 21155-21161.
32. Koike, S., Keino-Masu, K., Ohto, T. and Masu, M. (2006) The N-terminal hydrophobic sequence of autotaxin (ENPP2) functions as a signal peptide. Genes Cells 11, 133-142.
33. Tanaka, M., Okudaira, S., Kishi, Y., Ohkawa, R., Iseki, S., Ota, M., Noji, S., Yatomi, Y., Aoki, J. and Arai, H. (2006) Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic Acid. J. Biol. Chem. 281, 25822-25830.
34. van Meeteren, L. A., Ruurs, P., Stortelers, C., Bouwman, P., van Rooijen, M. A., Pradere, J. P., Pettit, T. R., Wakelam, M. J., Saulnier-Blache, J. S., Mummery, C. L., Moolenaar, W. H. and Jonkers, J. (2006) Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol. Cell Biol. 26, 5015-5022.
35. Bachner, D., Ahrens, M., Betat, N., Schroder, D. and Gross, G. (1999) Developmental expression analysis of murine autotaxin (ATX). Mech. Dev. 84, 121-125.
36. Fuss, B., Baba, H., Phan, T., Tuohy, V. K. and Macklin, W. B. (1997) Phosphodiesterase I, a novel adhesion molecule and/or cytokine involved in oligodendrocyte function. J. Neurosci. 17, 9095-9103.
37. Fox, M. A., Colello, R. J., Macklin, W. B. and Fuss, B. (2003) Phosphodiesterase-I alpha/autotaxin: a counteradhesive protein expressed by oligodendrocytes during onset of myelination. Mol. Cell. Neurosci. 23, 507-519.
38. Narita, M., Goji, J., Nakamura, H. and Sano, K. (1994) Molecular cloning, expression, and localization of a brain-specific phosphodiesterase I/nucleotide pyrophosphatase (PD-I alpha) from rat brain. J. Biol. Chem. 269, 28235-28242.
39. Dennis, J., Nogaroli, L. and Fuss, B. (2005) Phosphodiesterase-Ialpha/ autotaxin (PD-Ialpha/ATX): a multifunctional protein involved in central nervous system development and disease. J. Neurosci. Res. 82, 737-742.
40. Tokumura, A., Fujimoto, H., Yoshimoto, O., Nishioka, Y., Miyake, M. and Fukuzawa, K. (1999) Production of lysophosphatidic acid by lysophospholipase D in incubated plasma of spontaneously hypertensive rats and Wistar Kyoto rats. Life Sci. 65, 245-253.
41. Clair, T., Aoki, J., Koh, E., Bandle, R. W., Nam, S. W., Ptaszynska, M. M., Mills, G. B., Schiffmann, E., Liotta, L. A. and Stracke, M. L. (2003) Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res. 63, 5446-5453.
42. Paxinos, G., Watson, C., Pennisi, M. and Topple, A. (1985) Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. J. Neurosci. Methods 13, 139-143.
43. Brauer, A. U., Savaskan, N. E., Plaschke, M., Ninnemann, O. and Nitsch, R. (2003) Cholecystokinin expression after hippocampal deafferentiation: molecular evidence revealed by differential display-reverse transcription- polymerase chain reaction. Neuroscience 121, 111-121.
44. Brauer, A. U., Nitsch, R. and Savaskan, N. E. (2004) Identification of macrophage/microglia activation factor (MAF) associated with late endosomes/lysosomes in microglial cells. FEBS Lett. 563, 41-48.
45. Colognato, H., Ramachandrappa, S., Olsen, I. M. and ffrench-Constant, C. (2004) Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development. J. Cell Biol. 167, 365-375.
46. Mccarthy, K. D. and Devellis, J. (1980) Preparation of separate astroglial and oligodendroglial cell-cultures from rat cerebral tissue. J. Cell Biol. 85, 890-902.
47. Reynolds, R. and Wilkin, G. P. (1988) Development of macroglial cells in rat cerebellum. 2. An In situ immunohistochemical study of oligodendroglial lineage from precursor to mature myelinating cell. Development 102, 409-425.
48. Ness, J. K., Valentino, M., Mciver, S. R. and Goldberg, M. P. (2005) Identification of oligodendrocytes in experimental disease models. Glia 50, 321-328.
49. Meier, S., Brauer, A. U., Heimrich, B., Schwab, M. E., Nitsch, R. and Savaskan, N. E. (2003) Molecular analysis of Nogo expression in the hippocampus during development and following lesion and seizure. FASEB J. 17, 1153-1155.
50. Meier, S., Brauer, A. U., Heimrich, B., Nitsch, R. and Savaskan, N. E. (2004) Myelination in the hippocampus during development and following lesion. Cell. Mol. Life Sci. 61, 1082-1094.
51. Sato, K., Malchinkhuu, E., Muraki, T., Ishikawa, K., Hayashi, K., Tosaka, M., Mochiduki, A., Inoue, K., Tomura, H., Mogi, C., Nochi, H., Tamoto, K. and Okajima, F. (2005) Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources. J. Neurochem. 92, 904-914.
52. Dehn, D., Burbach, G. J., Schafer, R. and Deller, T. (2006) NG2 upregulation in the denervated rat fascia dentata following unilateral entorhinal cortex lesion. Glia 53, 491-500.
53. Wu, V. W., Nishiyama, N. and Schwartz, J. P. (1998) A culture model of reactive astrocytes: increased nerve growth factor synthesis and reexpression of cytokine responsiveness. J. Neurochem. 71, 749-756.
54. Weiner, J. A., Hecht, J. H. and Chun, J. (1998) Lysophosphatidic acid receptor gene vzg-1/lp(A1)/edg-2 is expressed by mature oligodendrocytes during myelination in the postnatal murine brain. J. Comp. Neurol. 398, 587-598.
55. Lee, H. Y., Bae, G. U., Jung, I. D., Lee, J. S., Kim, Y. K., Noh, S. H., Stracke, M. L., Park, C. G., Lee, H. W. and Han, J. W. (2002) Autotaxin promotes motility via G protein-coupled phosphoinositide 3-kinase gamma in human melanoma cells. FEBS Lett. 515, 137-140.
56. Hama, K., Aoki, J., Fukaya, M., Kishi, Y., Sakai, T. and Suzuki, R. (2004) Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA(1). J. Biol. Chem. 279, 17634-17639.
57. Lee, H. Y., Clair, T., Mulvaney, P. T., Woodhouse, E. C., Aznavoorian, S., Liotta, L. A. and Stracke, M. L. (1996) Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin. J. Biol. Chem. 271, 24408-24412.
58. Koh, E., Clair, T., Woodhouse, E. C., Schiffmann, E., Liotta, L. and Stracke, M. (2003) Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities. Cancer Res. 63, 2042-2045.
59. Gijsbers, R., Aoki, J., Arai, H. and Bollen, M. (2003) The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site. FEBS Lett. 538, 60-64.
60. Das, A. K. and Hajra, A. K. (1989) Quantification, characterization and fatty-acid composition of lysophosphatidic acid in different rat tissues. Lipids 24, 329-333.
61. Sugiura, T., Nakane, S., Kishimoto, S., Waku, K., Yoshioka, Y., Tokumura, A. and Hanahan, D. J. (1999) Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells. Biochim. Biophys. Acta 1440, 194-204.
62. Fox, M. A., Alexander, J. K., Afshari, F. S., Colello, R. J. and Fuss, B. (2004) Phosphodieterase-I alpha/autotaxin and IFAK phosphorylation during controls cytoskeletal organization myelination. Mol. Cell. Neurosci. 27, 140-150.
63. Holtsberg, F. W., Steiner, M. R., Keller, J. N., Mark, R. J., Mattson, M. P. and Steiner, S. M. (1998) Lysophosphatidic acid induces necrosis and apoptosis in hippocampal neurons. J. Neurochem. 70, 66-76.
64. Dawson, J., Hotchin, N., Lax, S. and Rumsby, M. (2003) Lysophosphatidic acid induces process retraction in CG-4 line oligodendrocytes and oligodendrocyte precursor cells but not in differentiated oligodendrocytes. J. Neurochem. 87, 947-957.
65. Ramakers, G. J. and Moolenaar, W. H. (1998) Regulation of astrocyte morphology by RhoA and lysophosphatidic acid. Exp. Cell Res. 245, 252-262.
66. Schilling, T., Lehmann, F., Ruckert, B. and Eder, C. (2004) Physiological mechanisms of lysophosphatidylcholine-induced de-ramification of murine microglia. J. Physiol. (Lond) 557, 105-120.
67. Kinouchi, H., Imaizumi, S., Yoshimoto, T., Yamamoto, H. and Motomiya, M. (1990) Changes of polyphosphoinositides, lysophospholipid, and free fatty-acids in transient cerebral-ischemia of rat brain. Mol. Chem. Neuropathol. 12, 215-228.
68. Sun, G. Y., Lin, T. N., Simonyi, A., Wang, Q., Chen, J. J., Cheung, W. M., He, Y. Y., Xu, J., Sun, A. Y., Hsu, C. Y. and Sun, G. Y. (2004) Transient focal cerebral ischemia induces group IIA secretory phospholipase A2 in reactive astrocytes in rat brain. J. Neurochem. 88, 40.
69. Tigyi, G., Hong, L., Yakubu, M., Parfenova, H., Shibata, M. and Leffler, C. W. (1995) Lysophosphatidic acid alters cerebrovascular reactivity in piglets. Am. J. Physiol. 268, H2048-H2055.
70. Sayas, C. L., Moreno-Flores, M. T., Avila, J. and Wandosell, F. (1999) The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like Tau phosphorylation. J. Biol. Chem. 274, 37046-37052.
71. Umemura, K., Yamashita, N., Yu, X., Arima, K., Asada, T., Makifuchi, T., Murayama, S., Saito, Y., Kanamaru, K., Goto, Y., Kohsaka, S., Kanazawa, I. and Kimura, H. (2006) Autotaxin expression is enhanced in frontal cortex of Alzheimer-type dementia patients. Neurosci. Lett. 400, 97-100.
72. Inoue, M., Rashid, M. H., Fujita, R., Contos, J. J. A., Chun, J. and Ueda, H. (2004) Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat. Med. 10, 712-718.
73. Hammack, B. N., Fung, K. Y., Hunsucker, S. W., Duncan, M. W., Burgoon, M. P., Owens, G. P. and Gilden, D. H. (2004) Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult. Scler. 10, 245-260.
74. Corcoran, D. L., Feingold, E., Dominick, J., Wright, M., Harnaha, J., Trucco, M., Giannoukakis, N. and Benos, P. V. (2005) Footer: A quantitative comparative genomics method for efficient recognition of cis-regulatory elements. Genome Res. 15, 840-847.
75. Acarin, L., Gonzalez, B. and Castellano, B. (2001) Triflusal posttreatment inhibits glial nuclear factor-kappaB, down-regulates the glial response, and is neuroprotective in an excitotoxic injury model in postnatal brain. Stroke 32, 2394-2402.
76. Wilhelmsson, U., Li, L., Pekna, M., Berthold, C. H., Blom, S., Eliasson, C., Renner, O., Bushong, E., Ellisman, M., Morgan, T. E. and Pekny, M. (2004) Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration. J. Neurosci. 24, 5016-5021.
77. Stefan, C., Gijsbers, R., Stalmans, W. and Bollen, M. (1999) Differential regulation of the expression of nucleotide pyrophosphatases/phosphodiesterases in rat liver. Biochim. Biophys. Acta 1450, 45-52.